The results presented in this study showed that the level of anti-inflammatory cytokines IL-10 and TGF-β1 decreased in the Colitis and Colitis/CP groups, while SPH treatment elevated the levels of IL-10 and TGF-β1 compared with the control peptide. This evidence concerns the gene IL10 and colitis.